Fever-Tree (FEVR) Stock Rises 4% After Broker Upgrade and Insider Buy
TLDR
- Kepler Cheuvreux upgraded Fever-Tree from “Hold” to “Buy,” lifting its price target to 910 pence from 900 pence
- FEVR rose 4.2% to 828 pence on Tuesday, outperforming the FTSE Mid-Cap 250 which fell 0.4%
- U.S. off-trade growth jumped to 16% in July-August, up from 6% in Q1 2026
- Kepler raised EBITDA estimates by 5.8% for 2026 and 8.5% for 2027
- A company director bought £348,457 worth of stock on September 11
Fever-Tree (LON: FEVR) stock climbed 4.2% to 828 pence on Tuesday after Kepler Cheuvreux upgraded the stock to “Buy” from “Hold.” The broker set a new price target of 910 pence, up from 900 pence, pointing to around 14.5% upside from its reference price.
Kepler said the recent dip in the stock is an attractive entry point, citing accelerating U.S. growth and better earnings visibility.
U.S. momentum has clearly picked up. Off-trade growth in the U.S. hit 16% in July and August, compared to just 6% in the first quarter of 2026. Kepler credits improved distribution, merchandising and marketing through Molson Coors.
… Continue reading the full article at the original source below.
This content is automatically aggregated. Full credit goes to the original publisher (coincentral.com).
